Meanwhile, Zhao et al. [110] proposed that NEAT1’s interaction with the miR-124/BACE1 axis could make it a novel target for Alzheimer’s disease treatment. The gene discussed is BACE1; the disease is early-onset autosomal dominant Alzheimer disease.